Epirubicin (E), cisplatin (C) and capecitabine (X) in first-line chemotherapy for patients with advanced gastric cancer

Authors :: Soo-Mee Bang
S.H. Park
Soon Nam Lee
Eun Kyung Cho
S.-A. Im
Woon-Kee Lee
Dongbok Shin
Jinseon Lee
Source :: Journal of Clinical Oncology. 22:4074-4074
Publication Year :: 2004
Publisher :: American Society of Clinical Oncology (ASCO), 2004.
Abstract: 4074 Background: ECF has been regarded as a highly active regimen for the advanced gastric cancer. Capecitabine (X) is an oral fluoropyrimidine carbamate and may be less toxic and more active than ...

Subjects :: Oncology
Cisplatin
Cancer Research
medicine.medical_specialty
business.industry
Advanced gastric cancer
Capecitabine
Regimen
Internal medicine
medicine
First line chemotherapy
business
Epirubicin
medicine.drug

Full Text Access

Tools